Gebze Ataşehir

Prof.

Tayfun Kutlu

He continues to work as the Director of IVF Center of Anadolu Medical Center Hospital, where he's taken office in early 2020.

In-vitro Fertilization (IVF) Department

Speciality

Reproductive Endocrinology and Infertility Assisted Reproduction Treatments: IVF Endoscopic Surgery: Laparoscopy – Hysteroscopy

Education

Istanbul University, Istanbul Faculty of Medicine 1985-1991
Istanbul Zeynep Kamil Obstetrics and Pediatrics Training and Research Hospital 1992-1996

Institutions Worked At

Assoc. Prof. Dr. Tayfun Kutlu graduated from Istanbul University Istanbul Medical Faculty in 1991. He completed his residency training on Obstetrics and Gynecology in Istanbul Zeynep Kamil Obstetrics and Pediatrics Training and Research Hospital between 1992-1996. He undertook the position of IVF Center Unit Supervisor as of 2014 in IVF Center of Zeynep Kamil Obstetrics and Pediatrics Training and Research Hospital, where he served between 2000-2019. In 2017, he was granted the title of Associate Professor and Training Officer. He continues to work as the Director of IVF Center of Anadolu Medical Center Hospital, where he's taken office in early 2020.

Turkish Society of Gynecology and Obstetrics
Society of Reproductive Medicine and Surgery
American Society for Reproductive Medicine (ASRM)
European Society of Human Reproduction and Embryology (ESHRE)
Büyük Kulüp Association
Fenerbahçe Sports Club

Recent Advances in ART, 6th MSRM Congress, Antalya, 19.04.2007
Practical Course for Diagnostic and Therapeutic Hysteroscopy, Hysteroscopy practices training, Zeynep Kamil Obstetrics and Pediatrics Training and Research Hospital, 14.06.2005
Advanced Course On Perinatal Ultrasound, First-Second Trimester Scanning, Cervical Assessment, Doppler Assessment, Istanbul, 16.11.2001 -18.11.2001
Prenatal Diagnosis and Treatment Course, Obstetric Ultrasonography, Prenatal Diagnosis and Treatment, I.U. Istanbul Faculty of Medicine, Department of Obstetrics and Gynecology, 27.04.1998 -01.05.1998
Andrology Course, Andrology, Antalya, Course, 25.09.1997 -25.09.1997 6. Course on Doppler-Ultrasonography in Gynecology, Antalya, 27.09.1997 -27.09.1997

Certificates:

Clinical Research and Good Clinical Practices Training for Ethics Committee Members and Candidates (2016)
Urgent Obstetrics Care Clinician Training (2015)
Laparoscopic Surgery Course, Laparoscopic Surgery, Endometriosis Adenomyosis Association (2012)
Assisted Reproduction Treatment Methods Certificate (2005)
Laparoscopy (2006)
Hysteroscopy (2005)
Neonatal Resuscitation Training (2002)

1. Kutlu T, Özkaya E, Şanverdi I, Çakar E, Ayvacı H, Devranoğlu B, Karateke A. Acute fetal heart rate tracing changes secondary to cigarette smoking in third trimester pregnancies. The Journal of Maternal Fetal Neonatal Medicine, 2017 30(12),1407-1409.

2. Kutlu T, Özkaya E, Ayvacı H, Devranoğlu B, Şanverdi İ, Şahin Y, Şenol T, Karateke A. Area under curve of temporal estradiol measurements for prediction of the detrimental effect of estrogen exposure on implantation. International Journal of Gynecology and Obstetrics, 2016, 135(2),168-171.

3. Kutlu T, TuğrulS, Aydın A, Oral Ö. Tuberculous meningitis in pregnancy presenting as hyperemesis gravidarum. J Matern Fetal Neonatal Med. 2007 Apr;20(4):357-9.

4. Kutlu T, Tuğrul S, Aran T, Uslu H, Eren S, Oral Ö. Combined administration of misoprostol in the first and second trimester missed abortion cases. Clin Exp Obstet Gynecol. 2006;33(4):226-8.

5. Kutlu T, Ficicoglu C, Başaran T, Başaran E, Topaloğlu T. Mammographic breast density changes after 1 year of tibolone use. Maturitas. 2004 Jun 15;48(2):133-6.

6. Ozkaya E, Kutlu T, Abide Yayla C, Kayatas Eser S, Sanverdi I, Devranoglu B. Area under the curve of temporal estrogen and progesterone measurements during assisted reproductive technology: Which hormone is the main determinant of cycle outcome? J Obstet Gynaecol Res. 2018; 44(2):263-269.

7. Sanverdi I, Kutlu T, Bilgic BE, Incebiyik A. A comparison of treatment results of the different treatment protocols in patients with poor ovarian response. Gynecol Endocrinol. 2018; 34(6):524-527.

8. Kara M, Kutlu T, Sofuoglu K, Devranoglu B, Cetinkaya T. Association between serum estradiol level on the hCG administration day and IVF-ICSI outcome. Iran J Reprod Med. 2012, 10(1),53-58.

9. Tuğrul S, Kutlu T, Pekin O, Bağlam E, Kıyak H, Oral Ö. Clinical, endocrine and metabolic effects of acarbose, alpha glucosidase inhibitor, in overweight and non-overweight PCOS patients. Fertil Steril. 2008 Oct;90(4):1144-8

10. Ficicioglu C, Kutlu T, Baglam E, Bakacak Z. Early follicular antimullerian hormone as an indicator of ovarian reserve. Fertil Steril. 2006 Mar;85(3):592-6.

11. Oral O, Kutlu T, Aksoy E, Ficicioglu C, Uslu H, Tugrul S. The effects of oxidative stress on outcomes of assisted reproductive techniques. J Assist Reprod Genet. 2006 Feb;23(2):81-5.

12. Ficicioglu C, Kutlu T, Taşdemir S, Altuntaş L. The effects of different gonadotropin releasing hormone analogues in IVF cycles. MEFSJ. 2005; 10(3): 212-8.

13. Ficicioglu C, Kutlu T, Demirbasoglu S, Mulayim B. The role of inhibin B as a basal determinant of ovarian reserve. Gynecol Endocrinol. 2003 Aug;17(4):287-93.

14. Ficicioglu C, Kutlu T. The role of androgens in the aetiology and pathology of pre-eclampsia. J Obstet Gynaecol. 2003 Mar;23(2):134-7.

15. Çakar E, Yavuz MM, Kutlu T, Ayvacı Taşan H, Cogendez E, Beydilli Nacak G, Özkaya E, Kayataş Eser S. Ivf versus spontan singleton pregnancies fetal and maternal outcomes in a tertiary care hospital. International Journal of Medical Science and Clinical Invention 2018, 5(03): 3583-3587.

16. Kara M, Sofuoglu K, Kutlu T, Devranoglu B, Çetinkaya T.Comparison of the efficacy and cost-effectiveness of highly purified urinary follicle stimulating hormone (HP-uFSH) and recombinant follicle stimulating hormone (r FSH) in poor responders. Journal of the Dow University of Health Sciences Karachi 2011, Vol. 5 (2): 43-46

17. Yiginer O, Dogan M, Gun I, Kutlu T, Degirmencioglu G, Guliyev İ, Tokatli A, Kilicaslan F. The effects of supraphysiological estrogen levels on ventricular repolarization parameters. Kardiol Pol. 2018 Feb 5. doi: 10.5603/KP.a2018.0037.

18. Şahin Y, Özkaya E, Kayataş Eser S, Kutlu T, Şanverdi İ, Tunalı G, Karateke A. Serum substance P concentrations to predict oocyte maturation index and clinical pregnancy. Gynecological Endocrinology, 2017, 33(3), 203-207.

19. Aydın GA, Yavuz A, Terzi H, Kutlu T. Assessment of the relationship of basal serum anti-mullerian hormone levels with oocyte quality and pregnancy outcomes in patients undergoing ICSI. Iran J Reprod Med 2015, 13(4), 231-236.

20. Tugrul S, Oral O, Guclu M, Kutlu T, Uslu H, Pekin O. Significance of Doppler ultrasonography in the diagnosis of polycystic ovary syndrome. Clin Exp Obstet Gynecol. 2006;33(3):154-8.

21. Tugrul S, Yildirim G, Pekin O, Uslu H, Kutlu T, Eren S. Comparison of two forms of continuous combined hormone replacement therapy with respect to metabolic effects. Arch Gynecol Obstet. 2007 May;275(5):335-9.

22. Çakar E, Ayvaci Tasan H, Kumru P, Cogendez E, Tarhan N, Kutlu T, Özkaya E, Kayatas Eser S. Combined use of oestradiol and progesterone to support luteal phase in antagonist intracytoplasmic sperm injection cycles of normoresponder women: a case-control study. Journal of Obstetrics and Gynaecology. 2019, 1-6.

23. Kurek Eken M, Sahin Ersoy G, Yayla Abide Ç, Sanverdi İ, Devranoglu B, Kutlu T, Çevik Ö. Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome. Journal of Obstetrics and Gynaecology. 2019,1-6.

24. Abide Yayla C, Ozkaya E, Beydilli Nacak G, Sanverdi I, Devranoglu B, Bostanci Ergen E, Kilicci C, Kutlu T. High estrogen exposure may not be detrimental on endometrial receptivity in women with PCOS. Gynecol Endocrinol. 2018; 34(9), 798-803.

25. Abide Yayla Ç, Özkaya E, Kayataş Eser S, Şanverdi İ, Devranoğlu B, Kutlu T. Association of basal serum androgen levels with ovarian response and ICSI cycle outcome. Ir J Med Sci. 2018; 187(2):409-415.

26. Ovayolu A, Özdamar Ö, Gün İ, Arslanbuğa CY, Kutlu T, Tunalı G,Uluhan R.The assesment of follicular fluid presepsin levels in poor ovarian responder women and its relationship with the reproductive outcomes. Int J Clin Exp Med 2015;8(6):9961-9966.

27. Bilgic BE. Yayla Abide C. Ozkaya E. Kutlu T. Ayla Ş.Şanverdi İ. Tunalı G. Yucel E. Kanbur S. Role of Oocyte Morphological Abnormality Rates on the Embryo Development and Implantation. Gynecol Obstet Reprod Med 2018; DOI:10.21613/GORM.2018.755

28. Bozdağ H, Akdeniz E, Devranoğlu B, Haksever M, Bilgiç BE, Kutlu T. Cytoplasmic abnormalities of mature oocytes have a significant effect on fertilization in Bologna poor responders. Turkish journal of medical sciences. 2018; 48(4), 750-758.

29. Yayla Abide Ç. Özkaya E. Kayataş Eser S. Devranoğlu B. Bilgiç BE. Kutlu T. Serum Albumin Level Adjusted Progesterone Level on the Trigger Day is Not a Significant Predictor of Clinical Pregnancy. Gynecol Obstet Reprod Med 2018; DOI:10.21613/GORM.2017.771

30. Devranoglu B. Yayla Abide Ç, Özkaya E. Şenol T. Kutlu T. Kayatas Eser S. Coagulation Tests at Trigger Day in Patients with Factor V Leiden Mutation to Predict Implantation Failure.Gynecol Obstet Reprod Med 2018; DOI:10.21613/GORM.2017.754

31. E Özkaya, ÇA Yayla, SK Eser, B Devranoğlu, I Şanverdi, T Kutlu (2018). Short Term Alterations of Hormone Profile Following Oocyte Pick-Up in Women with Polycystic Ovarian Syndrome to Assess the Effect of Multiple Needle Entries Into The Ovarian Cortex and Stroma. Gynecology Obstetrics & Reproductive Medicine 24 (1), 17-21

32. Çakar E, Yavuz MM, Kutlu T, Ayvacı Taşan H, Cogendez E, Beydilli Nacak G, Özkaya E, Eser SK (2018). Ivf versus spontan singleton pregnancies fetal and maternal outcomes in a tertiary care hospital. International Journal of Medical Science and Clinical invention; 5(3), 3583-3587.

33. BE Bilgiç, E Özkaya, T Kutlu, SK Eser, İ Sanverdi, SB Türkmen (2017). Transvajinal Folikül Aspirasyonunu Takiben Oosit Toplanabilen ve Toplanamayan Kötü Yanıtlı Hastaların Siklus Karakteristiklerinin Karşılaştırılması. Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi 14 (4)

34. Kutlu T, Özkaya E, Kumru P, Ayvacı H, Devranoğlu B, Şanverdi İ, Şahin Y, Sağlam B, Karateke A (2017). Clinical analyses of successful and previously failed intracytoplasmic sperm injection cycle parameters in patients with poor ovarian reserve. Turkish Journal of Obstetrics and Gynecology, 2017 Mar;14(1):58-63.

35. Özkaya E. Şahin Y. Kayataş Eser S. Albayrak B. Bulduk O. Sanverdi İ. Kutlu T (2017). Does the Modification of Starting Gonadotropin Dose During ICSI Cycle Have Any Significant Impact on Cycle Outcome? Gynecol Obstet Reprod Med; 23(3):138-142

36. Kutlu H T, Özkaya E, Sanverdi I, Devranoğlu B, Ipekçi C, Konukçu B, Yavuz S, Karateke A (2016). Relationship Between The Estradiol- Progesterone Alterations After Ovulation Trigger And Treatment Success In IUI Cycles. Turk J Obstet Gynecol;13:56-61

37. Şanverdi İ, Özkaya E, Kutlu T, Şenol T, Akalın M, Akalın E S, Şahin Y, Karateke A (2016). Non-invasive prediction of implantation window in controlled hyperstimulation cycles: Can the time from the menstrual day at embryo transfer to expected menstrual cycle give a clue? Turkish Journal of Obstetrics and Gynecology, 13, 116-22.

38. Özüm G, Özdamar Ö, Gün I, Sofuoğlu K, Kutlu H T, Tunalı G (2016). Histeroskopi yapılan primer ve sekonder infertil hastalarda histerosalpingografi ve transvaginal ultrasonografinin tanısal degerinin incelenmesi. Zeynep Kamil Tıp Bülteni, 47(1), 1-5. Doi: 10.16948/zktb.08928

39. Selçuk S, Küçükbaş M, Yenidede I, Kayataş Eser S, Eser A, Çam Ç, Kutlu H T (2016). The outcomes of controlled ovarian hyperstimulation/intrauterine insemination in patients with unilateral tubal occlusion on hysterosalpingograph. Turkish Journal of Obstetrics and Gynecology, 13(1), 7-10

40. Selçuk S, Özkaya E, Eser A, Kuyucu M, Kutlu H T, Devranoğlu B, Sofuoğlu K, Dayıcıoğlu V E (2016). Characteristics and outcomes of in vitro fertilization in different phenotypes of polycystic ovary syndrome. Turkish Journal of Obstetrics and Gynecology, 13(1), 1-6.

41. Temizkan O, Çöğendez E, Sanverdi I, Temizkan S, Kutlu H T, Ayhan I, Arıcı B, Aşıcıoğlu O (2015). GnRH agonist veya antagonist ile down regülasyon yapılan ICSI/ET sikluslarında insan koryonik gonadotropin günü bakılan estradiol, prolaktin düzeylerinin embriyo kalitesi ve gebelik sonuçlarına etkisi. Sişli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital, 49(3), 174-180., Doi: 10.5350/SEMB. 20150302090129

42. Ayla Ş, Tunalı G, Körkoca N, Beyhan Sağlam, Ural M, Sofuoğlu K, Uslu B, Kutlu T, Devranoğlu B, Büyükbayrak EE, Şahin S. Tek ve Şartlı İki Embryo Transfer (Yönetmeliği) Sonrası Gebelik Oranları. Zeynep Kamil Tıp Bülteni,45 (4), 156-159, 2014

43. Baykal B, Çelik C, Bastu E, Kutlu T, Batu P, Abalı R, Eren S. Effect of Antral Follicle Count on in Vitro Fertilization Outcome. Antral Folikül Sayısının in Vitro Fertilizasyon Sonuçlari Üzerine Etkisi. J Clin Anal Med,, 5(4): 324-7, 2014

44. Şahin S, Selçuk S, Devranoğlu B, Kutlu T, Kuyucu M, Eroğlu M. Comparison of long GnRH agonist versus GnRH antagonist protocol in poor responders. J Turk Soc Obstet Gynecol,11, 203-206,2014.

45. Kara M, Kutlu T, Sofuoğlu K. Comparison of the Recombinant Versus Highly-Purified, Urinary Follicle-Stimulating Hormone (r-FSH vs. HP-uFSH) in the Polycystic Ovary Syndrom Patients who had Antagonist Cycle with In Vitro Fertilization-Embryo Transfer. Turkiye Klinikleri J Med Sci, 31(4):775-9, 2011.

46. Gürleyiğ E, Sanverdi I, Kutlu H T, Muyır R, Eren S (2007). Benign Adneksial Kitlelerin Laparoskopik Yönetimi. Haydarpasa Numune Egitim ve Arastırma Hastanesi Tıp Dergisi, 47(4), 469-473.

47. Kutlu H T, Aran T, Oral Ö, Gürleyiğ E, Altınkaş K, Önal G (2007). Perimenopozal Dönemde Molar Gebelik. Haydarpasa Numune Egitim ve Arastırma Hastanesi Tıp Dergisi, 47(1).

48. Aköz I, Ayas S, Kutlu H T, Pekin O, Eren S (2006). Tuba Uterina Leiomyomu. Zeynep Kamil Tıp Bülteni, 37(4), 95-96

49. Kutlu H T, Tuğrul A S, Çeçen F, Eren S (2006). Endometrial Örnekleme Öncesi Misoprostol Kullanımı. Kadın Dogum Dergisi, 4(4), 909-913

50. Gürleyiğ E, Kutlu H T, Altınkaş K, Önal G, Oral Ö (2006). Ektopik Gebeligin Yönetiminde Genel Hastane Deneyimimiz: Tedavi Seçiminde Cerrahı Etkileyen Faktörler. Kadın Dogum Dergisi, 5(1), 1006-1009

51. Kutlu T, Bağlam E, Genç Z, Eren S. Erken Doğum Tehditini Önceden Belirlemede Risk Puanı, Servikal Uzunluk ve Maternal Tükrük Östriol Seviyesinin Rolü. Zeynep Kamil Tıp Bülteni Jinekoloji-Obstetrik-Pediatri Klinikleri, 36 ( 2 ), 51 – 55, 2005.

52. Kutlu T, Bağlam E, Eren S. Twın Pregnancy Complıcated By Interlocking:A Case Report. Gynecology, Obstetrics & Reproductive Medicine, GORM,12 (1),47-49, 2006

53. Usta SS, Kutlu T, Eren S. Do Tibolone and Combined Hormone Replacement Therapy Have a Beneficial Effect on Plasma Lipid Levels in Hyper and Normocholesterolemic Postmenopausal Women? Gynecology, Obstetrics & Reproductive Medicine ( GORM ), 10 ( 3 ), 186 – 190, 2004.

54. Fıçıcıoğlu C, Kutlu T, Başaran T, Yaltı S, Gürbüz B, Taşdemir S. Yardımcı Üreme Tekniklerinde Kontrollü Over Hiperstimülasyon İçin Rekombinant FSH  ve  ile Saf Üriner FSH Kullanımının Karşılaştırılması. Klinik Bilimler & Doktor Dergisi, 10 ( 5 ), 579 – 584, 2004.

55. Aköz İ, Kılıçcı Ç, Kutlu T, Pekin O, Eren S. Sezaryen Sırasında Tesadüfen Saptanmış Adneksiyal Kitleler. Zeynep Kamil Tıp Bülteni Jinekoloji-Obstetrik-Pediatri Klinikleri, 35 ( 2 ), 61 – 65, 2004.

56. Kutlu T, Bozdağ H, Aköz İ, Pekin O, Usta S, Eren S. Sezaryen Sonrası Opioid Gereksinimini Azaltmada Tek Doz İndometasin Supozituar Kullanımının Yeri. Zeynep Kamil Tıp Bülteni Jinekoloji-Obstetrik-Pediatri Klinikleri, 34 ( 3 ), 1 – 4, 2003.

57. Bozdağ H, Ertekin K, Kutlu T, Öztürk G, Eren S. Akut Faz Reaktanı Olarak Ferritin ve Erken Doğum Tehdidinde Kullanımı. Zeynep Kamil Tıp Bülteni Jinekoloji-Obstetrik-Pediatri Klinikleri, 34 ( 1 ), 13-18, 2003.

58. Kutlu T, Başaran T, Fıçıcıoğlu C. Yardımcı Üreme Tekniklerinde Eksojen HCG Uygulama Günü E2 Düzeyinin Prognostik Değeri. Zeynep Kamil Tıp Bülteni Jinekoloji-Obstetrik-Pediatri Klinikleri, 33 ( 2 ), 1-4, 2002.

59. Tuğrul S, Köse G, Kutlu T, Demirören T. İntrauterin Gelişme Geriliğinde Maternal Serum Albümin ve Prealbümin Düzeyleri. Jinekoloji ve Obstetrik Dergisi, 13(2): 107-111, 1999.

60. Kara M, Tuğrul S, Kekovalı M, Özden S, Kutlu T, Eroğlu M. Kistik Ovarian Tümörlerde Video Laparoskopik Yaklaşım. Endoskopik Laparoskopik Minimal İnvaziv Cerrahi, 3 (3): 162-167, 1996.

61. Çetin A, Kara M, Kutlu T, Cantekin D. Gebelikte Asemptomatik Bakteriüri ve Maternal Anemi İle İlişkisi. Zeynep Kamil Tıp Bülteni Jinekoloji-Obstetrik-Pediatri Klinikleri, 28 ( 4 ): 260-263, 1996.

62. Fıçıcıoğlu C, Kalay B, Cantekin D, Ünlü R, Solmaz E, Kutlu T. Prematür Membran Rüptürü Olgularında Muhtemel Risk Faktörlerinin İrdelenmesi. PTT Hastanesi Tıp Dergisi, 17 ( 3 ): 289-298, 1995.

63. Çetin A, Kara M, Kutlu T, Cantekin D. İntraservikal Prostoglandin E2 Jel Aplikasyonu İle Doğum İndüksiyonu. PTT Hastanesi Tıp Dergisi, 16 ( 3 ): 289-294, 1994.

64. Kalay B, Fıçıcıoğlu C, Gürbüz A, Kumru A, Kutlu T. Fetal Solunum Hareketi ve NST: Preterm Prematür Membran Rüptüründe Koryoamnionit ve Perinatal Enfeksiyon Riskini Saptamada Zayıf Belirtiler. PTT Hastanesi Tıp Dergisi, 16 ( 2 ): 141-148, 1994.

65. Gürbüz A, Fıçıcıoğlu C, Kutlu T, Kalay B. Serviksin Premalign Lezyonlarına Güncel Yaklaşım. PTT Hastanesi Tıp Dergisi, 16 ( 2 ): 121-127, 1994.

66. Gürbüz A, Fıçıcıoğlu C, Kalay B, Kutlu T. Tekrarlayan Gebelik Kayıplarının Otoimmün Boyutu. PTT Hastanesi Tıp Dergisi, 16 ( 3 ): 279-287, 1994.

67. Fıçıcıoğlu C, Yıldırım A, Ünlü R, Cantekin D, Kutlu T. Erken Gebelik Bulantı ve Kusmalarında HCG’in Rolü. PTT Hastanesi Tıp Dergisi, 15 (3): 343-357, 1993.

68. Akın S, Fıçıcıoğlu C, Ünlü R, Cantekin D, Kutlu T. Perimenopozal Anormal Uterin Kanamalı Hastaların Endovajinosonografik Endometrial Kalınlık Değerlendirilmeleri. PTT Hastanesi Tıp Dergisi, 15 ( 3 ): 331-338, 1993.

69. Fıçıcıoğlu C, Ertekin K, Ünlü R, Kutlu T. HAIR-AN Sendromu. PTT Hastanesi Tıp Dergisi, 15 ( 1 ): 101-109, 1993.

Press & News

22 Eylül 2020 Salı

CUMHURİYET

Polikistik over sendromu ve tüp bebek

Show article

3 Şubat 2021 Çarşamba

POSTA

Kadınlarda infertilite nedenleri ve çözümleri

Show article

Areas of Interest

What is Embryo Transfer? How is Embryo Transfer Performed?

Embryo transfer is the process of placing embryos, developed in a laboratory setting outside the woman’s body during IVF treatment, into the prospective mother’s uterus. Defined as the fertilization of egg cells collected from the prospective mother with sperm cells taken from the prospective father in a laboratory environment, and then transferring them into the mother’s uterus, embryo transfer can assist couples who are unable to conceive naturally to achieve pregnancy.

What is Low Egg Reserve (AMH)?, Causes and Treatment

The decline in egg count in women is a common cause of infertility today. From a certain age, both the quantity and quality of a woman's eggs decrease, which can reduce the chances of fertilization and hinder the ability to conceive. This condition, indicating a decrease in the fertility hormone known as AMH (Anti-Müllerian Hormone), can sometimes also occur in young women. To learn more about low egg reserve, continue reading the rest of the text.

How to Improve Egg Reserve and Quality?

Egg reserve is an important term that helps understand a woman's fertility potential. This concept is used to assess a woman’s reproductive capacity and the quantity of eggs in her ovaries.

What is the Egg Freezing Procedure, and Who is Eligible?

Egg freezing is a reproductive option for women who wish to preserve their fertility potential for later in life. The procedure involves stimulating the ovaries with hormonal medications and freezing the mature eggs that are collected. In this way, individuals can create a reproductive plan that suits their lifestyle and needs

Causes, Symptoms, Diagnosis, and Treatment of Tubal Obstruction

Blocked fallopian tubes are a common issue affecting female reproductive health. These tubes facilitate fertilization by connecting the ovaries to the uterus. When a blockage occurs, it can disrupt this complex reproductive process and lead to infertility. The causes of blockage can include infections, endometriosis, or injuries from previous surgeries. Understanding the causes of these blockages, learning about diagnosis and treatment options, is crucial for couples wishing to conceive.

Glutathione Treatment in IVF Applications

To have a healthy baby, both the sperm and the egg must be healthy. However, free radicals generated as a result of metabolic events can accumulate in the body and lead to the deterioration of the egg or sperm. This can result in infertility issues. The antioxidant known as glutathione helps eliminate these accumulated radicals from the body, contributing to healthier pregnancies. For this reason, glutathione treatment is important for a healthier pregnancy process in IVF treatments. You can continue reading to learn more about glutathione treatment in IVF.

PRP Application in IVF Method

What is Polycystic Ovary Syndrome (PCOS), Its Symptoms, and Treatment

Polycystic ovary syndrome is a common health issue that affects women of reproductive age. The underlying cause of the syndrome may involve hormonal changes. Androgen hormones, which are typically associated with males, are present in women at certain levels. However, excessive production of these hormones can lead to various disorders. As a result, PCOS can manifest as disruptions in the menstrual cycle, changes in the skin and hair, and the formation of cysts in the ovaries. Although the primary cause of PCOS is still unknown, it is one of the most common causes of infertility. Additionally, there are several risk factors that may predispose individuals to the development of polycystic ovary syndrome. Family history, lifestyle habits, and certain medical conditions can trigger the development of PCOS. If not diagnosed early and treated, polycystic ovary syndrome can lead to long-term complications such as cardiovascular diseases and type 2 diabetes.

What is Infertility, Principles, Diagnosis, and Treatment

There are important steps in our bodies to become pregnant. The brain produces reproductive hormones, the egg matures, and ovulation releases it. The fallopian tubes capture the egg, and the sperm cells from the male partner travel to fertilize the egg. The fertilized egg implants in the uterus, marking the beginning of pregnancy. Disruptions in this complex process can prevent pregnancy from occurring. However, not every failed attempt is considered infertility. Now, let’s examine what infertility is.

What is Embryo Glue? Who is it Used For?

Embryo glue, used in in vitro fertilization treatments, helps create a strong and stable connection between the developing embryo and the uterine lining. You can read on for more information about embryo glue, which significantly increases the chances of successful implantation and pregnancy.

What is a Chip Baby? How is a Chip Baby Made?

Chip implantation in IVF is a medical procedure used to increase the chances of couples achieving pregnancy through natural means. In this method, the eggs of the prospective mother are stimulated and matured. Then, sperm collected from the prospective father is selected in a laboratory environment to fertilize the mother's eggs. The fertilized egg develops into an embryo, which is then placed into the mother's uterus. Chip implantation can be a hopeful option for couples facing infertility issues. The procedure is performed under the supervision of a medical expert and is tailored to the individual health conditions of the couples.

What is a Chocolate Cyst (Endometriosis), Symptoms, and Treatment

A chocolate cyst is a gynecological issue that has a significant impact on women's health. Known medically as endometriosis, a chocolate cyst occurs when tissue similar to the lining of the uterus (the endometrium) grows in areas outside the uterus. Genetic predisposition, hormonal imbalances, retrograde menstrual flow, and immune system issues can all play a role in the formation of chocolate cysts. The combination of these factors can lead to inflammation and bleeding in the endometrial tissue, resulting in chocolate cysts. The name "chocolate cyst" comes from the brownish, liquid-like substance contained within these cysts, which are typically found in the ovaries. Chocolate cysts can cause a range of symptoms, including painful menstrual periods, pelvic pain, pain during intercourse, and fertility issues. This condition can greatly affect women's quality of life and may require long-term treatment.

What is In Vitro Fertilization (IVF)? How is IVF Treatment Performed?

IVF treatment, applied to individuals who cannot conceive naturally, can be defined as the process of bringing together reproductive cells in a laboratory environment.

What is Polycystic Ovary Syndrome? Pregnancy Treatment

"Polycystic Ovary Syndrome" (PCOS), especially common in women who are overweight, can make it difficult to conceive, but it is not an insurmountable barrier.

Ovulation Period: What It Is, Symptoms, and Calculation Method

The ovulation period is when mature eggs are released from the ovaries in women. It is a key part of the menstrual cycle and plays an essential role in conception. There are several signs indicating the onset of ovulation. Women who wish to conceive can monitor these signs and use a specific calculation method to choose the most suitable time to try to become pregnant. Read on to learn more about the ovulation period.

Doctor Articles

All articles

3 Kasım 2023 Cuma

What is Infertility? 10 Steps to IVF Treatment

23 Ağustos 2023 Çarşamba

11 Questions to Increase Egg Reserve and Quality

Featured Cancer Articles